Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward

Gavi supports countries to introduce typhoid conjugate vaccine (TCV) with catch-up campaigns. Available TCVs are highly efficacious, equity-focused, and critical to curbing the expansion of antimicrobial resistance. Four Gavi-supported countries have introduced TCVs since 2018. In the wake of the CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Russell, Allyson L, Hampton, Lee M, Sinha, Antara, Luquero, Francisco J, Abdelwahab, Jalaa’
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Charting the Course Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236508/
https://www.ncbi.nlm.nih.gov/pubmed/37274531
http://dx.doi.org/10.1093/ofid/ofad042
_version_ 1785052944552427520
author Russell, Allyson L
Hampton, Lee M
Sinha, Antara
Luquero, Francisco J
Abdelwahab, Jalaa’
author_facet Russell, Allyson L
Hampton, Lee M
Sinha, Antara
Luquero, Francisco J
Abdelwahab, Jalaa’
author_sort Russell, Allyson L
collection PubMed
description Gavi supports countries to introduce typhoid conjugate vaccine (TCV) with catch-up campaigns. Available TCVs are highly efficacious, equity-focused, and critical to curbing the expansion of antimicrobial resistance. Four Gavi-supported countries have introduced TCVs since 2018. In the wake of the COVID-19 emergency, momentum is building to scale up TCV introduction worldwide, supported by global partners and Gavi’s funding for improved typhoid diagnostics.
format Online
Article
Text
id pubmed-10236508
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-102365082023-06-03 Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward Russell, Allyson L Hampton, Lee M Sinha, Antara Luquero, Francisco J Abdelwahab, Jalaa’ Open Forum Infect Dis Charting the Course Supplement Gavi supports countries to introduce typhoid conjugate vaccine (TCV) with catch-up campaigns. Available TCVs are highly efficacious, equity-focused, and critical to curbing the expansion of antimicrobial resistance. Four Gavi-supported countries have introduced TCVs since 2018. In the wake of the COVID-19 emergency, momentum is building to scale up TCV introduction worldwide, supported by global partners and Gavi’s funding for improved typhoid diagnostics. Oxford University Press 2023-06-02 /pmc/articles/PMC10236508/ /pubmed/37274531 http://dx.doi.org/10.1093/ofid/ofad042 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Charting the Course Supplement
Russell, Allyson L
Hampton, Lee M
Sinha, Antara
Luquero, Francisco J
Abdelwahab, Jalaa’
Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward
title Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward
title_full Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward
title_fullStr Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward
title_full_unstemmed Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward
title_short Progress in the Typhoid Conjugate Vaccine Program Rollout Supported by Gavi During the COVID-19 Pandemic and the Path Forward
title_sort progress in the typhoid conjugate vaccine program rollout supported by gavi during the covid-19 pandemic and the path forward
topic Charting the Course Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236508/
https://www.ncbi.nlm.nih.gov/pubmed/37274531
http://dx.doi.org/10.1093/ofid/ofad042
work_keys_str_mv AT russellallysonl progressinthetyphoidconjugatevaccineprogramrolloutsupportedbygaviduringthecovid19pandemicandthepathforward
AT hamptonleem progressinthetyphoidconjugatevaccineprogramrolloutsupportedbygaviduringthecovid19pandemicandthepathforward
AT sinhaantara progressinthetyphoidconjugatevaccineprogramrolloutsupportedbygaviduringthecovid19pandemicandthepathforward
AT luquerofranciscoj progressinthetyphoidconjugatevaccineprogramrolloutsupportedbygaviduringthecovid19pandemicandthepathforward
AT abdelwahabjalaa progressinthetyphoidconjugatevaccineprogramrolloutsupportedbygaviduringthecovid19pandemicandthepathforward

Ejemplares similares